Axsome Therapeutics, CVD Equipment, and AXTI show market activity

Various companies are seeing notable movement in the stock market. Axsome Therapeutics has seen a 16% year-to-date increase, driven by the growth of its depression treatment, Auvelity, which saw a 51% increase in net product sales. The company is also expanding its use of Auvelity to treat Alzheimer's disease agitation.

CVD Equipment Corporation recently surpassed its 200-day moving average, trading as high as $7.58. Despite recent analyst rating changes, the industrial products company reported quarterly revenue of $1.95 million and an EPS of $1.81.

AXTI, Inc. has experienced a significant breakout following a period of heavy institutional volume. After reaching a resistance level of $98.00, the stock is currently testing support at the $70-$71 range. The surge is attributed to increased demand for Indium Phosphide in AI data centers.